£1.3M
The Norwich-based diagnostics firm secured £1.3m immediately with up to £2m committed for 2021 from a syndicate of angel and local enterprise investors.
"There’s a vast, global potential in the application of our unique technology. We are using it to tackle Covid now, but it will also produce better vaccines and new diagnostic and therapeutic products in the future. The investment we have secured will enable us to attract new talent to the team at Iceni and maximise the significant opportunities we have in our pipeline."